SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

J.B.Chemicals & Pharmaceuticals informs about trading window closure

26 Sep 2024 Evaluate
J.B.Chemicals & Pharmaceuticals has informed that as per Company’s code of conduct framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, trading window for dealing in the securities of the Company will be closed from October 1, 2024 until 48 hours after the declaration of the unaudited financial results for the quarter and half year ending on September 30, 2024 by the Board of Directors of the Company.

The above information is a part of company’s filings submitted to BSE.

JB Chem & Pharma Share Price

1985.50 10.80 (0.55%)
17-Apr-2026 13:38 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1671.05
Dr. Reddys Lab 1229.60
Cipla 1236.50
Zydus Lifesciences 945.00
Lupin 2307.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×